A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

CITREPORE is an exciting addition to Acuitive's product portfolio and provides a unique opportunity for its use in numerous ...

Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a unique synthetic bioactive bone void filler, using ...

A veteran’s life has been forever changed after a selfless act for his community. Someone who saw his story wanted to do ...

Hello Health Rounds Readers! Today we have three studies presented at medical meetings, including one testing a device that ...

According to Miach Orthopaedics, “The BEAR Implant is the first disruptive technology in ACL [anterior cruciate ligament] ...

Simultaneously, the patient becomes aware of a salty taste because the intralobular ducts have not adequately resorbed sodium and chloride ions from the saliva. Furthermore, because salivary ...

The agency is alerting patients and providers to not use the implantable devices, made for soft tissue such as breast tissue.

Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=8016806 ...

aiming to provide temporary support to treated vessels while eventually being fully resorbed by the body. This technology seeks to address limitations of both permanent metallic stents and polymeric ...